US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
Acetaminophen use during pregnancy does not increase children’s risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and intellectual disability.
Acetaminophen use during pregnancy does not increase children’s risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and intellectual disability.
A new multicenter observational cohort study showed that sleep phase variability and daily activity amplitude measured through actigraphy were associated with risk of depression relapse.
A new multicenter observational cohort study showed that sleep phase variability and daily activity amplitude measured through actigraphy were associated with risk of depression relapse.
A multicenter randomized clinical trial evaluated whether internet-delivered cognitive resilience training (iCT-R) could prevent PTSD and MDD among paramedic recruits.
A multicenter randomized clinical trial evaluated whether internet-delivered cognitive resilience training (iCT-R) could prevent PTSD and MDD among paramedic recruits.
In a systematic review, greater severity of negative schizophrenia symptoms was associated with decreased health-related quality of life (HRQoL) and worse functional outcomes.
In a systematic review, greater severity of negative schizophrenia symptoms was associated with decreased health-related quality of life (HRQoL) and worse functional outcomes.
A randomized clinical trial (RCT) assessed whether a keto diet could offer therapeutic benefit in adults with treatment-resistant depression (TRD) and found a modest improvement in depression measures versus control diet.
A randomized clinical trial (RCT) assessed whether a keto diet could offer therapeutic benefit in adults with treatment-resistant depression (TRD) and found a modest improvement in depression measures versus control diet.
A large systematic review and meta-analysis found psychological and psychosocial interventions had minimal impact in individuals with co-occurring schizophrenia and substance use disorder (SUD).
A large systematic review and meta-analysis found psychological and psychosocial interventions had minimal impact in individuals with co-occurring schizophrenia and substance use disorder (SUD).
Evenamide add-on therapy improved outcomes in patients with treatment-resistant schizophrenia or inadequate antipsychotic response, according to post-hoc analysis findings.
Evenamide add-on therapy improved outcomes in patients with treatment-resistant schizophrenia or inadequate antipsychotic response, according to post-hoc analysis findings.
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
A long-term extension study found that adjunctive vagus nerve stimulation (VNS) had a durable benefit in patients with treatment-resistant major depression over 24 months.
A long-term extension study found that adjunctive vagus nerve stimulation (VNS) had a durable benefit in patients with treatment-resistant major depression over 24 months.
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
US youths with higher levels of ADHD symptom severity had significantly higher odds of initiating e-cigarette, cigarette, and other tobacco use over a 9-year follow-up.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
Acetaminophen use during pregnancy does not increase children’s risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and intellectual disability.
Acetaminophen use during pregnancy does not increase children’s risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and intellectual disability.
A new multicenter observational cohort study showed that sleep phase variability and daily activity amplitude measured through actigraphy were associated with risk of depression relapse.
A new multicenter observational cohort study showed that sleep phase variability and daily activity amplitude measured through actigraphy were associated with risk of depression relapse.
A multicenter randomized clinical trial evaluated whether internet-delivered cognitive resilience training (iCT-R) could prevent PTSD and MDD among paramedic recruits.
A multicenter randomized clinical trial evaluated whether internet-delivered cognitive resilience training (iCT-R) could prevent PTSD and MDD among paramedic recruits.
In a systematic review, greater severity of negative schizophrenia symptoms was associated with decreased health-related quality of life (HRQoL) and worse functional outcomes.
In a systematic review, greater severity of negative schizophrenia symptoms was associated with decreased health-related quality of life (HRQoL) and worse functional outcomes.
A randomized clinical trial (RCT) assessed whether a keto diet could offer therapeutic benefit in adults with treatment-resistant depression (TRD) and found a modest improvement in depression measures versus control diet.
A randomized clinical trial (RCT) assessed whether a keto diet could offer therapeutic benefit in adults with treatment-resistant depression (TRD) and found a modest improvement in depression measures versus control diet.
A large systematic review and meta-analysis found psychological and psychosocial interventions had minimal impact in individuals with co-occurring schizophrenia and substance use disorder (SUD).
A large systematic review and meta-analysis found psychological and psychosocial interventions had minimal impact in individuals with co-occurring schizophrenia and substance use disorder (SUD).
Evenamide add-on therapy improved outcomes in patients with treatment-resistant schizophrenia or inadequate antipsychotic response, according to post-hoc analysis findings.
Evenamide add-on therapy improved outcomes in patients with treatment-resistant schizophrenia or inadequate antipsychotic response, according to post-hoc analysis findings.
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
A long-term extension study found that adjunctive vagus nerve stimulation (VNS) had a durable benefit in patients with treatment-resistant major depression over 24 months.
A long-term extension study found that adjunctive vagus nerve stimulation (VNS) had a durable benefit in patients with treatment-resistant major depression over 24 months.
Of the 3.3% of youth in a recent study that had exclusively undergone non-stimulant therapy for ADHD, what percentage reported prescription stimulant misuse in the past year?
Of the 3.3% of youth in a recent study that had exclusively undergone non-stimulant therapy for ADHD, what percentage reported prescription stimulant misuse in the past year?
T or F: According to the DSM-5-TR, ADHD is not diagnosed if the symptoms of inattention and hyperactivity occur exclusively during the course of a psychotic disorder.
T or F: According to the DSM-5-TR, ADHD is not diagnosed if the symptoms of inattention and hyperactivity occur exclusively during the course of a psychotic disorder.
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.
Vladimir Maletic, MD, MS, discusses living with, treating, and managing pediatric ADHD over the summer months. Dr Maletic gives practical advice for clinicians treating these patients and knowledge to share with caretakers.
Vladimir Maletic, MD, MS, discusses living with, treating, and managing pediatric ADHD over the summer months. Dr Maletic gives practical advice for clinicians treating these patients and knowledge to share with caretakers.
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD.
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD.
Manpreet K Singh, MD, MS, director, offers tips for clinicians to maintain manage expectations and the best possible care for patients with ADHD throughout the holiday season.
Manpreet K Singh, MD, MS, director, offers tips for clinicians to maintain manage expectations and the best possible care for patients with ADHD throughout the holiday season.
Greg Mattingly, MD, discusses the “hot topics” in pediatric attention-deficient/hyperactivity disorder (ADHD) that were presented at the recent Psych Congress in San Antonio.
Greg Mattingly, MD, discusses the “hot topics” in pediatric attention-deficient/hyperactivity disorder (ADHD) that were presented at the recent Psych Congress in San Antonio.
Dr Maletic is interviewed about the pandemic’s impact on different age groups of children with pediatric ADHD and how parents and schools can support children during the back-to-school transition.
Dr Maletic is interviewed about the pandemic’s impact on different age groups of children with pediatric ADHD and how parents and schools can support children during the back-to-school transition.
Increased screen time, diet changes, social impacts affects and other COVID-19 pandemic outcomes impact children with pediatric ADHD at varying levels depending on disorder severity, says Vladimir Maletic, MD, MS.
Increased screen time, diet changes, social impacts affects and other COVID-19 pandemic outcomes impact children with pediatric ADHD at varying levels depending on disorder severity, says Vladimir Maletic, MD, MS.
Edward Kaftarian, MD, Steering Committee, Psych Congress, provides an update on the current state of HIPAA requirements for clinicians practicing via telehealth.
Edward Kaftarian, MD, Steering Committee, Psych Congress, provides an update on the current state of HIPAA requirements for clinicians practicing via telehealth.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
Psych Congress Co-Chair Greg Mattingly, MD, breaks down the key pharmacologic differences between the US Food and Drug Administration (FDA)-approved vesicular monoamine transporter 2 (VMAT-2) inhibitors for the treatment of TD.
In this video, Psych Congress Steering Committee Member Steven Chan, MD, MBA, FAPA, FAMIA, offers an overview of the most pressing topics in digital mental health.
In this video, Psych Congress Steering Committee Member Steven Chan, MD, MBA, FAPA, FAMIA, offers an overview of the most pressing topics in digital mental health.
In this video, Michael Asbach, DMSc, PA-C, walks clinicians through some key clinical considerations for navigating diagnostic ambiguity when assessing patients for bipolar II disorder.
In this video, Michael Asbach, DMSc, PA-C, walks clinicians through some key clinical considerations for navigating diagnostic ambiguity when assessing patients for bipolar II disorder.
In this video filmed at Psych Congress 2025, Steering Committee member Desiree Matthews, PMHNP-BC, discusses the ways in which digital tools can be leveraged to reduce provider burnout.
In this video filmed at Psych Congress 2025, Steering Committee member Desiree Matthews, PMHNP-BC, discusses the ways in which digital tools can be leveraged to reduce provider burnout.
In this video, Craig Chepke, MD, DFAPA, discusses real-world findings that clinicians should be aware of when considering the use of oral or LAI antipsychotics for schizophrenia treatment.
In this video, Craig Chepke, MD, DFAPA, discusses real-world findings that clinicians should be aware of when considering the use of oral or LAI antipsychotics for schizophrenia treatment.
In this video filmed on-site at Psych Congress 2025, faculty member Timothy Wilens, MD, discusses the role that digital therapeutics may play in the management of attention-deficit/hyperactivity disorder (ADHD).
In this video filmed on-site at Psych Congress 2025, faculty member Timothy Wilens, MD, discusses the role that digital therapeutics may play in the management of attention-deficit/hyperactivity disorder (ADHD).
Filmed at the 2025 Psych Congress, Jonathan Meyer, MD, offers an updated approach for clinicians navigating clozapine monitoring following the end of Risk Evaluation and Mitigation Strategy (REMS) program.
Filmed at the 2025 Psych Congress, Jonathan Meyer, MD, offers an updated approach for clinicians navigating clozapine monitoring following the end of Risk Evaluation and Mitigation Strategy (REMS) program.
In this video, Psych Congress Steering Committee Member Edward Kaftarian, MD, dives into potential legal gray areas that clinicians may encounter when engaging in cross-state telepsychiatry.
In this video, Psych Congress Steering Committee Member Edward Kaftarian, MD, dives into potential legal gray areas that clinicians may encounter when engaging in cross-state telepsychiatry.
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.